Novartis and PeptiDream expand peptide discovery collaboration in deal worth over $2.8bn
The agreement builds on the companies’ peptide-drug conjugate collaboration announced in 2019
Read More
The agreement builds on the companies’ peptide-drug conjugate collaboration announced in 2019
Read MoreMore than two million cases of breast cancer were diagnosed globally in 2022
Read MoreBreast cancer is currently the most commonly diagnosed cancer in the UK, affecting around 56,000 people annually
Read MoreIt is estimated that up to 50 million people in the US have an autoimmune disease
Read MoreMay 1, 2024 | News, Regulatory
Approximately 520,000 new cases of colorectal cancer were diagnosed in Europe in 2020
Read MoreThere are more than 100 types of pneumococcal bacteria, which can affect adults differently than children
Read MoreApr 30, 2024 | News, Regulatory
It is estimated that more than 13,960 new cases of invasive cervical cancer were diagnosed in the US last year
Read MoreApr 30, 2024 | News, Regulatory
More than 550,000 new cases of breast cancer were diagnosed in Europe in 2022
Read MoreApr 30, 2024 | News, Healthcare
Findings from the report reveal factors that could have contributed to the spread of antimicrobial resistance
Read MoreApr 29, 2024 | News, Regulatory
The fully-human EGFR-MET bispecific antibody has been recommended as a first-line treatment option
Read MoreAn estimated 10% of adults and 24.6% of adolescents are affected by the inflammatory skin condition
Read MoreApr 29, 2024 | News, Regulatory
More than 38,000 people worldwide are currently affected by the rare genetic bleeding disorder
Read MoreAccount Specialist - Respiratory - Kent & Medway
Medical Science Liaison - Specialist Female Health - South UK
Head of Partnerships - Ostomy Care - UK & RoI
Account Specialist - Respiratory - Lothian & Borders